Sweat Analysis as Prognosticator After Heart Attack

CompletedOBSERVATIONAL
Enrollment

24

Participants

Timeline

Start Date

March 21, 2022

Primary Completion Date

March 31, 2023

Study Completion Date

March 31, 2023

Conditions
Acute Myocardial Infarction
Interventions
DIAGNOSTIC_TEST

Examination and analysis of sweat and blood samples at baseline and at follow up

Subjects will be assessed at baseline (as inpatients) and at 4-6 weeks at follow-up as outpatients according to standard operating procedures. Sweat samples will be collected using the CE certified Macroduct Sweat Collector and inflammatory parameters measured. Venous blood will be drawn and inflammatory parameters, Troponin-I and nt-proBNP measured. Further examinations include measurement of left ventricular ejection fraction by echocardiography at baseline and blood pressure, heart rate, risk scores and health information will be collected at baseline and follow up.

DIAGNOSTIC_TEST

Examination and analysis of sweat and blood samples at baseline

Sweat samples will be collected using the CE certified Macroduct Sweat Collector and inflammatory parameters measured. Venous blood will be drawn and inflammatory parameters, Troponin-I and nt-proBNP measured. Blood pressure, heart rate, risk scores and health information will collected.

Trial Locations (1)

70185

Department of cardiology, Örebro

All Listed Sponsors
collaborator

University Hospital, Basel, Switzerland

OTHER

lead

Region Örebro County

OTHER